borderline significantP = .05
The study demonstrated that metformin was associated with a borderline significant reduction in the FAI ( P = .05) and with a reduction in the serum concentration of LH-stimulated testosterone (T) ( P = .03). 44 Long-term studies have shown improvement in menstrual abnormalities in about 50% after use of metformin. 45 A recent update of the Cochrane review of insulin-sensitising agents and PCOS included 4227 participants.